first biocompatible pharmaceutical formulations progress to preclinical models new sustained-release drug delivery platforms for peptides, melanocortins aim to predict drug release kinetics from new ...
EDINBURGH, Scotland--(BUSINESS WIRE)--Neurocentrx (the Company), a biopharmaceutical company specialising in oral ketamine for the treatment of mood disorders and other neurological indications, today ...
BOONTON, N.J., March 5, 2018 /PRNewswire/ -- Enteris BioPharma, Inc., a biotechnology company developing innovative drug products built around its proprietary delivery technologies, announced today ...
MORRISVILLE, N.C., Dec. 21, 2020 (GLOBE NEWSWIRE) -- Novan, Inc. (“the Company” or “Novan”) (Nasdaq: NOVN), today announced it has entered into a Master Services Agreement (MSA) with Catalent, which ...
LEXINGTON, Mass., Aug. 19, 2019 /PRNewswire/ -- Pulmatrix, Inc. (NASDAQ: PULM) has received a grant from the United States Patent and Trademark Office for US Pat. No. 10376465. Granted claims cover ...
VANCOUVER, BC / ACCESS Newswire / July 23, 2025 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTC PINK:BNXTF)(FSE:BXT), a bioscience innovator specializing in advanced drug delivery ...
The Cabinet of Ministers granted approval for the proposal furnished by the Minister of Urban Development, Construction and Housing to include the following laws and amendments expected to be newly ...
MELBOURNE, Australia, Sept. 28, 2025 (GLOBE NEWSWIRE) -- CLINUVEL today announced that it is advancing new sustained-release liquid drug formulations in a preclinical program evaluating various drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback